Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Commentary

Identifying, Improving Safety Gaps in Sterile Pharmacy Compounding Systems and Practices: Part I
Commentary
Identifying, Improving Safety Gaps in Sterile Pharmacy Compounding Systems and Practices: Part I
02/24/2021
Damon Birkemeier, PharmD, FDA/ISMP safe medication management fellow, discusses survey results concerning compounding technologies and common safety errors, as well as some of the biggest perceived challenges.
Damon Birkemeier, PharmD, FDA/ISMP safe medication management fellow, discusses survey results concerning compounding technologies and common safety errors, as well as some of the biggest perceived challenges.
Damon Birkemeier, PharmD,...
02/24/2021
Pharmacy Learning Network
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
Commentary
Predicting the Need for SGLT2 Inhibitors for Future Heart Failure
02/23/2021
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“The SGLT2i are an expensive group of drugs in comparison to other goal-directed medical therapies for HfrEF, says Mark Munger, PharmD. “Perhaps this data might assist in formulary decisions and oversight use of these medications.”
“The SGLT2i are an expensive...
02/23/2021
Pharmacy Learning Network

Advertisement

Commentary
What Happened to the Influenza Virus?
02/19/2021
“Reports of low influenza activity thus far have eased the anxieties and fears of many individuals during this ongoing COVID-19 pandemic,” says Yvette C Terrie, BS Pharm, RPh, consultant pharmacist. “Many individuals including HCPs are...
“Reports of low influenza activity thus far have eased the anxieties and fears of many individuals during this ongoing COVID-19 pandemic,” says Yvette C Terrie, BS Pharm, RPh, consultant pharmacist. “Many individuals including HCPs are...
“Reports of low influenza...
02/19/2021
Pharmacy Learning Network
How Do We Achieve Optimal Population Cardiovascular Health?
Commentary
How Do We Achieve Optimal Population Cardiovascular Health?
02/10/2021
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor, Pharmacotherapy and Internal Medicine, University of Utah, discusses the declining rate of cardiovascular health across the world, and highlights what pharmacists can do in order to help support the 2020 goals...
Mark Munger, PharmD, professor,...
02/10/2021
Pharmacy Learning Network
Commentary
Tips for Increasing Error Reporting
02/04/2021
Jill Paslier, PharmD, CSP, ISMP fellow, reviews six best practices that organizations can use in order to optimize reporting systems and their ability to learn about patient safety factors in their system.
Jill Paslier, PharmD, CSP, ISMP fellow, reviews six best practices that organizations can use in order to optimize reporting systems and their ability to learn about patient safety factors in their system.
Jill Paslier, PharmD, CSP, ISMP...
02/04/2021
Pharmacy Learning Network

Advertisement

Commentary
The Expanding Clinical Benefits Linked With Metformin Use: New Study Provides More Data Suggesting Metformin is Associated With Reduced COVID-19 Mortality Rates
02/02/2021
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh,...
“Research indicates that metformin may exert the various clinical effects via different signaling pathways; however, the precise mechanisms have not yet been determined and research is ongoing,” says Yvette C. Terrie, BS Pharm, RPh,...
“Research indicates that...
02/02/2021
Pharmacy Learning Network
Update on Hypertension Epidemiology and Treatment for 2021
Commentary
Update on Hypertension Epidemiology and Treatment for 2021
02/01/2021
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses recent hypertension research and explains why treatment is important for intensive blood pressure control.
Mark Munger, PharmD, discusses...
02/01/2021
Pharmacy Learning Network
Remote Precepting: Expanding Opportunities for PharmD Experiential Learning
Commentary
Remote Precepting: Expanding Opportunities for PharmD Experiential Learning
01/27/2021
"With many PharmD candidates facing an unprecedented situation of some APPE rotations being canceled and graduation dates potentially delayed due to the COVID-19 pandemic, it is imperative that institutions and preceptors continue to create...
"With many PharmD candidates facing an unprecedented situation of some APPE rotations being canceled and graduation dates potentially delayed due to the COVID-19 pandemic, it is imperative that institutions and preceptors continue to create...
"With many PharmD candidates...
01/27/2021
Pharmacy Learning Network

Advertisement

Walmart and the Opioid Epidemic: Is There a Lack of Corporate Responsibility?
Commentary
Walmart and the Opioid Epidemic: Is There a Lack of Corporate Responsibility?
01/26/2021
Michael Cawley, PharmD, discusses the recent news of the Department of Justice saying it was suing Walmart for unlawfully dispensed controlled substances through their pharmacies, and stresses the need for more corporate responsibility.
Michael Cawley, PharmD, discusses the recent news of the Department of Justice saying it was suing Walmart for unlawfully dispensed controlled substances through their pharmacies, and stresses the need for more corporate responsibility.
Michael Cawley, PharmD,...
01/26/2021
Pharmacy Learning Network
Budget Impact Forecasts for Novel Drugs Informs Utilization Management Strategies
Commentary
Budget Impact Forecasts for Novel Drugs Informs Utilization Management Strategies
01/19/2021
Pavel Lavitas, PharmD, BCPS, clinical team lead, Clinical Pharmacy Services, uses new medications to treat sickle cell disease as an example of how the curation of pipeline intelligence, clinical trial analysis, and claims-based data...
Pavel Lavitas, PharmD, BCPS, clinical team lead, Clinical Pharmacy Services, uses new medications to treat sickle cell disease as an example of how the curation of pipeline intelligence, clinical trial analysis, and claims-based data...
Pavel Lavitas, PharmD, BCPS,...
01/19/2021
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use